Researcher Sponsorship: Lung Cancer

Sponsor the Lung Cancer Research Team

Month after month, your sponsorship accelerates lung cancer research toward new breakthroughs

Every year in France, lung cancer affects nearly 50,000 people. Lung cancer is the leading cause of cancer-related deaths among men and the second leading cause among women. Advancing lung cancer research and discovering new treatments is a critical public health issue. Lung cancer is often diagnosed too late. When it is detected at a metastatic stage, treatments remain largely ineffective...

It is for these patients that the high-level expertise of Dr. Françoise Farace’s and Professor Benjamin Besse’s team is absolutely essential; it is for them that your donation makes a direct difference.

• The leading cause of cancer-related death in men
• The second leading cause of cancer death among women
• More than 49,000 new cases per year
• More than 30,000 deaths per year

Through your sponsorship, become a driving force for innovation and accelerate lung cancer research for the direct benefit of patients!

● Innovating to improve lung cancer care: three flagship research programs:
● Understanding how the disease progresses over time using a simple blood test (analysis of DNA and circulating tumor cells)
● Identifying the mechanisms involved in treatment
resistance ● Predicting the risk of relapse

Goal: to develop new personalized treatments for metastatic lung cancer

Benefits for patients:

● Access to the most effective treatment from the moment of diagnosis
● Real-time monitoring of the disease
● Preventing and predicting the risk of relapse

Annual program budget: €150,000

 

Becoming a sponsor means taking part in a major scientific adventure every day

What if, for just €8.50 a month*, you could help accelerate lung cancer research?

With a regular donation of at least €25 per month (or €8.50 after tax deduction), you become a valued partner of your research team.

Your sponsorship provides essential support for bringing innovative lung cancer projects to fruition.

 

Our lung
cancer research will move forward thanks to you

 Dr. Françoise Farace, Director of the Rare Circulating Cells Analysis Laboratory

Without you, we wouldn’t be able to carry out certain research projects… Thanks to sponsorships, we can pursue exploratory research projects that don’t receive institutional grants. Yet this research is essential for validating new scientific concepts. Sponsors provide us with tangible support by funding the personnel needed to carry out our work. Our relationship with sponsors is exceptional because it allows us to step outside our research bubble, and I always appreciate the opportunity to share the latest advances in the research we’re conducting thanks to them.

Professor Benjamin Besse, Chair of the Department of Medical Oncology and medical oncologist

The ongoing support we receive from our sponsors is essential... Lung cancer is a type of cancer whose symptoms appear late, which is why, in most cases, the disease is diagnosed at a very advanced stage. With the regular support of our sponsors, lung cancer research is making great strides. We now have powerful techniques to help us understand how the disease progresses over time. Thanks to our researcher sponsorships, we can explain our projects and our progress “in real time.” This direct relationship is unique. Sharing our results with our sponsors is just as important as sharing them with the scientific community—and much more moving!

 

*after a 66% tax deduction

 

 Colorectal Cancer Childhood Cancer Gynecologic Cancers Living Better with Cancer Skin Cancer Lung Cancer Prostate Cancer Sarcomas Breast Cancer Brain Tumors